Literature DB >> 30312017

Curcumin Ameliorates Memory Deficits by Enhancing Lactate Content and MCT2 Expression in APP/PS1 Transgenic Mouse Model of Alzheimer's Disease.

Wei-Tian Lu1,2, Shan-Quan Sun1,2, Yu Li1, Shi-Ye Xu1,2, Sheng-Wei Gan1,2, Jin Xu1,2, Guo-Ping Qiu1, Fei Zhuo1, Si-Qin Huang3, Xu-Li Jiang4, Juan Huang1,2.   

Abstract

Curcumin is a natural product with several anti-Alzheimer's disease (AD) neuroprotective properties. This study aimed to investigate the effects of curcumin on memory deficits, lactate content, and monocarboxylate transporter 2 (MCT2) in APP/PS1 mouse model of AD. APP/PS1 transgenic mice and wild-type (WT) C57BL/6J mice were used in the present study. Spatial learning and memory of the mice was detected using Morris water-maze test. Cerebral cortex and hippocampus lactate contents were detected using lactate assay. MCT2 expression in the cerebral cortex and hippocampus was examined by immunohistochemistry and Western blotting. Results showed that spatial learning and memory deficits were improved in curcumin-treated APP/PS1 mouse group compared with those in APP/PS1 mice group. Brain lactate content and MCT2 protein level were increased in curcumin-treated APP/PS1 mice than in APP/PS1 mice. In summary, our findings indicate that curcumin could ameliorate memory impairments in APP/PS1 mouse model of AD. This phenomenon may be at least partially due to its improving effect on the lactate content and MCT2 protein expression in the brain. Anat Rec, 302:332-338, 2019.
© 2018 Wiley Periodicals, Inc. © 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Alzheimer's disease; curcumin; lactate; long-term memory; monocarboxylate transporter

Mesh:

Substances:

Year:  2018        PMID: 30312017     DOI: 10.1002/ar.23969

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  6 in total

1.  Curcumin slows the progression of Alzheimer's disease by modulating mitochondrial stress responses via JMJD3-H3K27me3-BDNF axis.

Authors:  Jingna Li; Shanshan Wang; Simiao Zhang; Dan Cheng; Xiaopeng Yang; Yutong Wang; Honglei Yin; Yajun Liu; Yanqiu Liu; Hongying Bai; Shuang Geng; Yunliang Wang
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

Review 2.  Glucose Metabolism, Neural Cell Senescence and Alzheimer's Disease.

Authors:  Qianqian Wang; Linyan Duan; Xingfan Li; Yifu Wang; Wenna Guo; Fangxia Guan; Shanshan Ma
Journal:  Int J Mol Sci       Date:  2022-04-14       Impact factor: 6.208

3.  Modulation of the Astrocyte-Neuron Lactate Shuttle System contributes to Neuroprotective action of Fibroblast Growth Factor 21.

Authors:  Yan Sun; Yue Wang; Su-Ting Chen; Ying-Jie Chen; Jie Shen; Wen-Bing Yao; Xiang-Dong Gao; Song Chen
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

Review 4.  Lactate Is Answerable for Brain Function and Treating Brain Diseases: Energy Substrates and Signal Molecule.

Authors:  Ming Cai; Hongbiao Wang; Haihan Song; Ruoyu Yang; Liyan Wang; Xiangli Xue; Wanju Sun; Jingyun Hu
Journal:  Front Nutr       Date:  2022-04-28

5.  Dihuang-Yinzi Alleviates Cognition Deficits via Targeting Energy-Related Metabolism in an Alzheimer Mouse Model as Demonstrated by Integration of Metabolomics and Network Pharmacology.

Authors:  Guanghui Han; Weizhe Zhen; Yuan Dai; Hongni Yu; Dongyue Li; Tao Ma
Journal:  Front Aging Neurosci       Date:  2022-04-01       Impact factor: 5.702

Review 6.  Lactate metabolism in human health and disease.

Authors:  Xiaolu Li; Yanyan Yang; Bei Zhang; Xiaotong Lin; Xiuxiu Fu; Yi An; Yulin Zou; Jian-Xun Wang; Zhibin Wang; Tao Yu
Journal:  Signal Transduct Target Ther       Date:  2022-09-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.